Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 25, 2024

Primary Completion Date

October 20, 2024

Study Completion Date

September 20, 2025

Conditions

HeartburnAcid-dependent Diseases of the Gastrointestinal TractSymptomatic Treatment of Gastric and Duodenal Ulcers

Interventions

DRUG

Antareit

A single dose of T or R drug in each of 2 periods of the study 2 h prior to food intake

Trial Locations (2)

RECRUITING

"Llc Certa Clinic", Moscow

RECRUITING

"Limited Liability Company Research Center Eco-Safety", Saint Petersburg

All Listed Sponsors

lead

Valenta Pharm JSC

INDUSTRY